TCT 2019: One-Year PARTNER 3 Outcomes Show Better Quality Of Life With TAVR

An analysis of the PARTNER 3 trial shows transcatheter aortic replacement with Edwards Sapien 3 yields better health status outcomes than surgical valve replacement after one year.